Adenosine 2a Receptor | List of Frontiers open access articles

Brief Research Report

Published on 20 Sep 2022

Chronic, but not sub-chronic, stress increases binge-like alcohol consumption in male and female c57BL6 mice

in Motivation and Reward

William McCarthy
Shama N. Huq
Kristen Allen
Lindsay Scally
Avelina Petri
Madeline Wujek
Benjamin D. Sachs

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2022.958342

4,263 views
5 citations

Original Research

Published on 05 Dec 2018

Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression

in Cardiac Electrophysiology

Marina Cerrone
Chantal J. M. van Opbergen
Kabir Malkani
Natasha Irrera
Mingliang Zhang
Toon A. B. Van Veen
Bruce Cronstein
Mario Delmar

Frontiers in Physiology

doi 10.3389/fphys.2018.01750

5,100 views
12 citations

Original Research

Published on 07 Aug 2020

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor

in Ethnopharmacology

Peng Zhao
Xuefang Liu
Haoran Dong
Yange Tian
Suxiang Feng
Di Zhao
Zhouxin Ren
Lanxi Zhang
Jiansheng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2020.01212

9,066 views
19 citations

Original Research

Published on 06 Sep 2022

Improvement of the sepsis survival rate by adenosine 2a receptor antagonists depends on immune regulatory functions of regulatory T-cells

in Microbial Immunology

Teng Zhang
Jie Zhao
Jingnan Fu
Guibing Chen
Tao Ma

Frontiers in Immunology

doi 10.3389/fimmu.2022.996446

3,947 views
7 citations

Original Research

Published on 11 Sep 2023

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer

in Cancer Immunity and Immunotherapy

Basma Zohair
Dounia Chraa
Ibtissam Rezouki
Hamza Benthami
Ibtissam Razzouki
Mohamed Elkarroumi
Daniel Olive
Mehdi Karkouri
Abdallah Badou

Frontiers in Immunology

doi 10.3389/fimmu.2023.1201632

9,897 views
24 citations

Mini Review

Published on 27 Mar 2018

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity

in Experimental Pharmacology and Drug Discovery

Stephan Menzel
Nicole Schwarz
Friedrich Haag
Friedrich Koch-Nolte

Frontiers in Pharmacology

doi 10.3389/fphar.2018.00266

10,211 views
31 citations

Original Research

Published on 16 Nov 2021

Combined Deficiency of the Melanocortin 5 Receptor and Adenosine 2A Receptor Unexpectedly Provides Resistance to Autoimmune Disease in a CD8+ T Cell-Dependent Manner

in Antigen Presenting Cell Biology

Trisha McDonald
Fauziyya Muhammad
Kayleigh Peters
Darren J. Lee

Frontiers in Immunology

doi 10.3389/fimmu.2021.742154

3,267 views
7 citations

Study Protocol

Published on 11 May 2022

Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography

in Neuropharmacology

Kyoji Okita
Toshihiko Matsumoto
Daisuke Funada
Maki Murakami
Koichi Kato
Yoko Shigemoto
Noriko Sato
Hiroshi Matsuda

Frontiers in Pharmacology

doi 10.3389/fphar.2022.820447

2,982 views
1 citation

Articles

Chronic, but not sub-chronic, stress increases binge-like alcohol consumption in male and female c57BL6 mice

Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss of Plakophilin-2 Expression

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor

Improvement of the sepsis survival rate by adenosine 2a receptor antagonists depends on immune regulatory functions of regulatory T-cells

The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer

Nanobody-Based Biologics for Modulating Purinergic Signaling in Inflammation and Immunity

Combined Deficiency of the Melanocortin 5 Receptor and Adenosine 2A Receptor Unexpectedly Provides Resistance to Autoimmune Disease in a CD8+ T Cell-Dependent Manner

Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography